This Article Full Text Full Text (PDF) Data Supplement Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yang, Q. Articles by Friedman, J.M. Search for Related Content PubMed PubMed Citation Articles by Yang, Q. Articles by Friedman, J.M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB FOLIC ACID Medline Plus Health Information Stroke Related Collections Health policy and outcome research Behavioral Changes and Stroke Risk Factors for Stroke Related Article

(Circulation. 2006;113:1335-1343.)
© 2006 American Heart Association, Inc.

Stroke

Improvement in Stroke Mortality in Canada and the United States, 1990 to 2002

Quanhe Yang, PhD; Lorenzo D. Botto, MD; J. David Erickson, DDS, PhD; Robert J. Berry, MD; Christie Sambell, PhD; Helen Johansen, PhD; J.M. Friedman, MD, PhD

From the National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Ga (Q.Y., J.D.E., R.J.B.); Department of Pediatrics, University of Utah, Salt Lake City (L.D.B.); Health Division, Statistics Canada, Ottawa, Ontario (C.S., H.J.); and Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada (J.M.F.).

Correspondence to Quanhe Yang, PhD, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, 1600 Clifton Rd, MS E86, Atlanta, GA 30333. E-mail qay0{at}cdc.gov

Received June 24, 2005; revision received December 19, 2005; accepted December 23, 2005.

Background— In the United States and Canada, folic acid fortification of enriched grain products was fully implemented by 1998. The resulting population-wide reduction in blood homocysteine concentrations might be expected to reduce stroke mortality if high homocysteine levels are an independent risk factor for stroke.

Methods and Results— In this population-based cohort study with quasi-experimental intervention, we used segmented log-linear regression to evaluate trends in stroke-related mortality before and after folic acid fortification in the United States and Canada and, as a comparison, during the same period in England and Wales, where fortification is not required. Average blood folate concentrations increased and homocysteine concentrations decreased in the United States after fortification. The ongoing decline in stroke mortality observed in the United States between 1990 and 1997 accelerated in 1998 to 2002 in nearly all population strata, with an overall change from –0.3% (95% CI, –0.7 to 0.08) to –2.9 (95% CI, –3.5 to –2.3) per year (P=0.0005). Sensitivity analyses indicate that changes in other major recognized risk factors are unlikely to account for the reduced number of stroke-related deaths in the United States. The fall in stroke mortality in Canada averaged –1.0% (95% CI, –1.4 to –0.6) per year from 1990 to 1997 and accelerated to –5.4% (95% CI, –6.0 to –4.7) per year in 1998 to 2002 (P0.0001). In contrast, the decline in stroke mortality in England and Wales did not change significantly between 1990 and 2002.

Conclusions— The improvement in stroke mortality observed after folic acid fortification in the United States and Canada but not in England and Wales is consistent with the hypothesis that folic acid fortification helps to reduce deaths from stroke.

---

 

CLINICAL PERSPECTIVE

Related Article:

Issue Highlights
Circulation 2006 113: 1271. [Full Text]

This article has been cited by other articles:

				Q.-H. Yang, L. D Botto, M. Gallagher, J. Friedman, C. L Sanders, D. Koontz, S. Nikolova, J D. Erickson, and K. Steinberg Prevalence and effects of gene-gene and gene-nutrient interactions on serum folate and serum total homocysteine concentrations in the United States: findings from the third National Health and Nutrition Examination Survey DNA Bank Am. J. Clinical Nutrition, July 1, 2008; 88(1): 232 - 246. [Abstract] [Full Text] [PDF]

				R. N. Rodionov and S. R. Lentz The Homocysteine Paradox Arterioscler. Thromb. Vasc. Biol., June 1, 2008; 28(6): 1031 - 1033. [Full Text] [PDF]

				J. Jentink, N. W. van de Vrie-Hoekstra, L. T. W. de Jong-van den Berg, and M. J. Postma Economic evaluation of folic acid food fortification in The Netherlands Eur J Public Health, June 1, 2008; 18(3): 270 - 274. [Abstract] [Full Text] [PDF]

				P. M. Ueland and S. Hustad Homocysteine and Folate Status in an Era of Folic Acid Fortification: Balancing Benefits, Risks, and B-vitamins Clin. Chem., May 1, 2008; 54(5): 779 - 781. [Full Text] [PDF]

				C. M. Pfeiffer, J. D. Osterloh, J. Kennedy-Stephenson, M. F. Picciano, E. A. Yetley, J. I. Rader, and C. L. Johnson Trends in Circulating Concentrations of Total Homocysteine among US Adolescents and Adults: Findings from the 1991-1994 and 1999-2004 National Health and Nutrition Examination Surveys Clin. Chem., May 1, 2008; 54(5): 801 - 813. [Abstract] [Full Text] [PDF]

				A D. Smith, Y.-I. Kim, and H. Refsum Is folic acid good for everyone? Am. J. Clinical Nutrition, March 1, 2008; 87(3): 517 - 533. [Abstract] [Full Text] [PDF]

				L. Hoey, H. McNulty, N. Askin, A. Dunne, M. Ward, K. Pentieva, J. Strain, A. M Molloy, C. A Flynn, and J. M Scott Effect of a voluntary food fortification policy on folate, related B vitamin status, and homocysteine in healthy adults Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1405 - 1413. [Abstract] [Full Text] [PDF]

				K. S McCully Homocysteine, vitamins, and vascular disease prevention Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1563S - 1568S. [Abstract] [Full Text] [PDF]

				C. Weikert, J. Dierkes, K. Hoffmann, K. Berger, D. Drogan, K. Klipstein-Grobusch, J. Spranger, M. Mohlig, C. Luley, and H. Boeing B Vitamin Plasma Levels and the Risk of Ischemic Stroke and Transient Ischemic Attack in a German Cohort Stroke, November 1, 2007; 38(11): 2912 - 2918. [Abstract] [Full Text] [PDF]

				L. B Bailey The rise and fall of blood folate in the United States emphasizes the need to identify all sources of folic acid Am. J. Clinical Nutrition, September 1, 2007; 86(3): 528 - 530. [Full Text] [PDF]

				A. de Bree, L. A van Mierlo, and R. Draijer Folic acid improves vascular reactivity in humans: a meta-analysis of randomized controlled trials Am. J. Clinical Nutrition, September 1, 2007; 86(3): 610 - 617. [Abstract] [Full Text] [PDF]

				C. M Pfeiffer, C. L Johnson, R. B Jain, E. A Yetley, M. F. Picciano, J. I Rader, K. D Fisher, J. Mulinare, and J. D Osterloh Trends in blood folate and vitamin B-12 concentrations in the United States, 1988 2004 Am. J. Clinical Nutrition, September 1, 2007; 86(3): 718 - 727. [Abstract] [Full Text] [PDF]

				J F Ludvigsson, U de Faire, A Ekbom, and S M Montgomery Vascular disease in a population-based cohort of individuals hospitalised with coeliac disease Heart, September 1, 2007; 93(9): 1111 - 1115. [Abstract] [Full Text] [PDF]

				H. Martin, B. Lindblad, and M. Norman Endothelial Function in Newborn Infants Is Related to Folate Levels and Birth Weight Pediatrics, June 1, 2007; 119(6): 1152 - 1158. [Abstract] [Full Text] [PDF]

				Q.-H. Yang, H. K Carter, J. Mulinare, R. Berry, J. Friedman, and J D. Erickson Race-ethnicity differences in folic acid intake in women of childbearing age in the United States after folic acid fortification: findings from the National Health and Nutrition Examination Survey, 2001-2002 Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1409 - 1416. [Abstract] [Full Text] [PDF]

				P. M. Ueland and R. Clarke Homocysteine and Cardiovascular Risk: Considering the Evidence in the Context of Study Design, Folate Fortification, and Statistical Power Clin. Chem., May 1, 2007; 53(5): 807 - 809. [Full Text] [PDF]

				C. Shirodaria, C. Antoniades, J. Lee, C. E. Jackson, M. D. Robson, J. M. Francis, S. J. Moat, C. Ratnatunga, R. Pillai, H. Refsum, et al. Global Improvement of Vascular Function and Redox State With Low-Dose Folic Acid: Implications for Folate Therapy in Patients With Coronary Artery Disease Circulation, May 1, 2007; 115(17): 2262 - 2270. [Abstract] [Full Text] [PDF]

				R. S. Cooper Using Public Health Indicators to Measure the Success of Hypertension Control Hypertension, April 1, 2007; 49(4): 773 - 774. [Full Text] [PDF]

				S. Kaul, A. A. Zadeh, and P. K. Shah Reply J. Am. Coll. Cardiol., March 27, 2007; 49(12): 1371 - 1371. [Full Text] [PDF]

				N. Akhtar Is Homocysteine a Risk Factor for Atherothrombotic Cardiovascular Disease? J. Am. Coll. Cardiol., March 27, 2007; 49(12): 1370 - 1371. [Full Text] [PDF]

				A D. Smith Folic acid fortification: the good, the bad, and the puzzle of vitamin B-12 Am. J. Clinical Nutrition, January 1, 2007; 85(1): 3 - 5. [Full Text] [PDF]

				K. M. Wilson, R. B. McCaw, L. Leo, E. Arning, S. Lhotak, T. Bottiglieri, R. C. Austin, and S. R. Lentz Prothrombotic Effects of Hyperhomocysteinemia and Hypercholesterolemia in ApoE-Deficient Mice Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 233 - 240. [Abstract] [Full Text] [PDF]

				R. M. Otero, H. B. Nguyen, D. T. Huang, D. F. Gaieski, M. Goyal, K. J. Gunnerson, S. Trzeciak, R. Sherwin, C. V. Holthaus, T. Osborn, et al. Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings. Chest, November 1, 2006; 130(5): 1579 - 1595. [Abstract] [Full Text] [PDF]

				I. H. Rosenberg and C. D. Mulrow Trials that matter: should we routinely measure homocysteine levels and "treat" mild hyperhomocysteinemia? Ann Intern Med, August 1, 2006; 145(3): 226 - 227. [Full Text] [PDF]

				A. J.M. de Craen, D. J. Stott, R. G.J. Westendorp, A. Khare, M. Lopez, J. Gogtay, E. P. Quinlivan, J. F. Gregory III, H. Refsum, A. D. Smith, et al. Homocysteine, B vitamins, and cardiovascular disease. N. Engl. J. Med., July 13, 2006; 355(2): 205 - 206. [Full Text] [PDF]